Subsequent studies revealed that ECHS1 exerts oncogenic or tumor-suppressive effects by mediating metabolic reprogramming in multiple cancers, as evidenced by its aberrant expression [42,44,45]. The gene discussed is ECHS1; the disease is cancer.